Photos

Global biopharma company in China meets BOI on investment plans, vaccine clinical trial projects in PH

  • Published on June 01, 2022
  • |

Global biopharma company in China meets BOI on investment plans, vaccine clinical trial projects in PH

Chinese global pharmaceutical firm, Yisheng Biopharma Co., Ltd. met with the Philippine Board of Investments (BOI) on May 11, 2022 to discuss the company’s plan to pursue investment interests in clinical trials and the opportunity for co-development/manufacturing and marketing of vaccines with a local company in the Philippines.

About the Author

Kate Shiene Austria

Information Officer III

Information Officer III under the Creative and Production Services Division of the Philippine Information Agency. 

Feedback / Comment

Get in touch